SCHEDULE 14C INFORMATION
Information Statement Pursuant to Section 14(c) of the Securities
Exchange Act of 1934
Check the appropriate box:
|X| Preliminary Information Statement
|_| Confidential, for Use of the Commission Only (as permitted by Rule
14c-5(d)(2))
|_| Definitive Information Statement
DOMAIN REGISTRATION, CORP.
(Name of Registrant as Specified in its Charter)
Payment of Filing Fee (Check the appropriate box):
|X| No fee required.
|_| Fee computed on table below per Exchange Act Rules 14c-5(g) and 0-11.
(1) Title of each class of securities to which transaction applies:
______________________________________________________________________
(2) Aggregate number of securities to which transaction applies:
______________________________________________________________________
(3) Per unit price or other underlying value of transaction computed
pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the filing fee
is calculated and state how it was determined):
______________________________________________________________________
(4) Proposed maximum aggregate value of transaction:
______________________________________________________________________
(5) Total fee paid:
______________________________________________________________________
|_| Fee paid previously with preliminary materials.
|_| Check box if any part of the fee is offset as provided by Exchange Act
Rule 0-11(a)(2) and identify the filing for which the offsetting fee as
paid previously. Identify the previous filing by registration statement
number, or the Form or Schedule and the date of its filing.
(1) Amount Previously Paid:
______________________________________________________________________
(2) Form, Schedule or Registration Statement No.:
______________________________________________________________________
(3) Filing Party:
______________________________________________________________________
(4) Date Filed:
______________________________________________________________________
DOMAIN REGISTRATION, CORP.
P.O. Box 031-088, Shennan Zhong Road,
Shenzhen City, P.R. China 518031
INFORMATION STATEMENT
(Dated January ____, 2009)
WE ARE NOT ASKING YOU FOR A PROXY AND YOU ARE REQUESTED NOT TO SEND US A PROXY.
THE "ACTIONS", DEFINED BELOW, HAVE ALREADY BEEN APPROVED BY WRITTEN CONSENT OF
THE SHAREHOLDERS WHO OWN A MAJORITY OF THE OUTSTANDING SHARES OF COMMON STOCK OF
CARLATERAL, INC. A VOTE OF THE REMAINING SHAREHOLDERS IS NOT NECESSARY.
GENERAL
This Information Statement is being furnished on or about the date first
set forth above to holders of record as of the close of business on December 19,
2008 (the "Record Date") of the common stock, par value $.001 per share ("Common
Stock"), of DOMAIN REGISTRATION, CORP., a Nevada corporation ("we" or the
"Company"), in connection with the following (the "Action"):
Amending our Articles of Incorporation to change the name of the Company
from Domain Registration, Corp. to BioPharm Asia, Inc.;
Our board of directors has unanimously approved, and stockholders holding
an aggregate of 3,960,000 shares, representing approximately 52.80% of the
7,500,000 shares of our Common Stock issued and outstanding as of the Record
Date, have consented in writing to, the Action. Such approval and consent are
sufficient under Section 78.320 of the Nevada Revised Statutes and our bylaws to
approve the Actions. The elimination of the need for a special or annual meeting
of stockholders to ratify or approve the Action is authorized by Section 78.320,
which provides that the written consent of stockholders holding at least a
majority of the voting power may be substituted for such a special or annual
meeting. Accordingly, no proxy of our stockholders will be solicited for a vote
on the Actions and this Information Statement is being furnished to stockholders
solely to provide them with certain information concerning the Actions in
accordance with the requirements of the Securities Exchange Act of 1934, as
amended, and the regulations promulgated thereunder, including particularly
Regulation 14C.
Our Company address is P.O. Box 031-088, Shennan Zhong Road,Shenzhen City,
P.R. China 518031.
1. CORPORATE NAME CHANGE
Effective upon us filing a Certificate of Amendment to the Articles of
Incorporation with the Secretary of State of Nevada on the 21st day after the
mailing of this Information Statement to all of the holders of record of our
Common Stock at the Record Date (the "Effective Date"), we intend to change our
Company's name from "Domain Registration, Corp." to "BioPharm Asia, Inc."
2. AMENDED ARTICLES OF INCORPORATION
The Company intends to file with the Secretary of State of Nevada a
Certificate of Amendment of Articles of Incorporation, in the form attached
hereto as Exhibit A, on or about the Effective Date. The Certificate of
Amendment will provide for our corporate name change to "BioPharm Asia, Inc ."
all as approved by the consent of the majority of our stockholders as of the
Record Date.
Change in Control
As previously disclosed by us in our Current Report on Form 8-K filed on
November 8, 2007, Max Time Enterprise Limited purchased an aggregate of
1,000,000 shares of our Common Stock at November 7, 2007 from Amy Hadley, Stuart
Curtis Nilson and Felicia May Nilson, our largest stockholder and only director
and officer at that time, which purchased shares represented 13.34% of the
shares then issued and outstanding, resulting in a change in the controlling
interest of our Company. The source of the funds with which the shares were
purchased was working capital.
January __, 2009 By order of the Board of Directors,
Hui Ping Cheng, Director
Exhibit A
